Hsiao-Chi Chen

Hsiao-Chi Chen

Auto-generated profile, based on publicly available information

Hsiao-Chi Chen

Center for Cell and Gene Therapy, Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Nature
Verified
Journal Article
Closed access
PDF file
EHEmmet Huang-Hobbs
Emmet Huang-Hobbs
YCYi-Ting Cheng
Yi-Ting Cheng
YKYeunjung Ko
Yeunjung Ko
ELEstefania Luna-Figueroa
Estefania Luna-Figueroa
BLBrittney Lozzi
Brittney Lozzi
BDBenjamin Deneen
Benjamin Deneen

26 April 2023 in Nature
Verified
Journal Article
Closed access
PDF file
YCYi-Ting Cheng
Yi-Ting Cheng
ELEstefania Luna-Figueroa
Estefania Luna-Figueroa
JWJunsung Woo
Junsung Woo
HCHsiao-Chi Chen
Hsiao-Chi Chen
ZLZhung-Fu Lee
Zhung-Fu Lee
BDBenjamin Deneen
Benjamin Deneen

16 June 2023 in Science
Verified
Journal Article
Closed access
DSDebosmita Sardar
Debosmita Sardar
YCYi-Ting Cheng
Yi-Ting Cheng
JWJunsung Woo
Junsung Woo
DCDong-Joo Choi
Dong-Joo Choi
ZLZhung-Fu Lee
Zhung-Fu Lee
BDBenjamin Deneen
Benjamin Deneen
Neuronal activity drives alterations in gene expression within neurons, yet how it directs transcriptional and epigenomic changes in neighboring astrocytes in functioning circuits is unknown. We found that neuronal activity induces widespread transcriptional up-regulation and down-regulation in astrocytes, highlighted by the identification of Slc22a3 as an activity-inducible astrocyte gene that encodes neuromodulator transporter Slc22a3 and regulates sensory processing in the mouse olfactory bulb. Loss of astrocytic Slc22a3 reduced serotonin levels in astrocytes, leading to alterations in histone serotonylation. Inhibition of histone serotonylation in astrocytes reduced the expression of γ-aminobutyric acid (GABA) biosynthetic genes and GABA release, culminating in olfactory deficits. Our study reveals that neuronal activity orchestrates transcriptional and epigenomic responses in astrocytes while illustrating new mechanisms for how astrocytes process neuromodulatory input to gate neurotransmitter release for sensory processing.

19 March 2021 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
AAAmir Arabzade
Amir Arabzade
YZYanhua Zhao
Yanhua Zhao
SVSrinidhi Varadharajan
Srinidhi Varadharajan
HCHsiao-Chi Chen
Hsiao-Chi Chen
SJSelin Jessa
Selin Jessa
SMStephen C. Mack
Stephen C. Mack
More than 60% of supratentorial ependymomas harbor a ZFTA–RELA (ZRfus) gene fusion (formerly C11orf95–RELA). To study the biology of ZRfus, we developed an autochthonous mouse tumor model using in utero electroporation (IUE) of the embryonic mouse brain. Integrative epigenomic and transcriptomic mapping was performed on IUE-driven ZRfus tumors by CUT&RUN, chromatin immunoprecipitation sequencing, assay for transposase-accessible chromatin sequencing, and RNA sequencing and compared with human ZRfus-driven ependymoma. In addition to direct canonical NFκB pathway activation, ZRfus dictates a neoplastic transcriptional program and binds to thousands of unique sites across the genome that are enriched with PLAGL family transcription factor (TF) motifs. ZRfus activates gene expression programs through recruitment of transcriptional coactivators (Brd4, Ep300, Cbp, Pol2) that are amenable to pharmacologic inhibition. Downstream ZRfus target genes converge on developmental programs marked by PLAGL TF proteins, and activate neoplastic programs enriched in Mapk, focal adhesion, and gene imprinting networks.Significance: Ependymomas are aggressive brain tumors. Although drivers of supratentorial ependymoma (ZFTA- and YAP1-associated gene fusions) have been discovered, their functions remain unclear. Our study investigates the biology of ZFTA–RELA-driven ependymoma, specifically mechanisms of transcriptional deregulation and direct downstream gene networks that may be leveraged for potential therapeutic testing.This article is highlighted in the In This Issue feature, p. 2113

31 July 2024 in Nature
Verified
Journal Article
Closed access
PDF file
HCHsiao-Chi Chen
Hsiao-Chi Chen
PHPeihao He
Peihao He
MMMalcolm McDonald
Malcolm McDonald
MWMichael R. Williamson
Michael R. Williamson
SVSrinidhi Varadharajan
Srinidhi Varadharajan
BDBenjamin Deneen
Benjamin Deneen

28 April 2023 in Science Advances
Verified
Journal Article
Closed access
DCDong-Joo Choi
Dong-Joo Choi
GAGeorgina Armstrong
Georgina Armstrong
BLBrittney Lozzi
Brittney Lozzi
PVPrashanth Vijayaraghavan
Prashanth Vijayaraghavan
SPSharon E. Plon
Sharon E. Plon
MZM. Zarowiecki
M. Zarowiecki
Glioma is a rare brain tumor with a poor prognosis. Familial glioma is a subset of glioma with a strong genetic predisposition that accounts for approximately 5% of glioma cases. We performed whole-genome sequencing on an exploratory cohort of 203 individuals from 189 families with a history of familial glioma and an additional validation cohort of 122 individuals from 115 families. We found significant enrichment of rare deleterious variants of seven genes in both cohorts, and the most significantly enriched gene was HERC2 ( P = 0.0006). Furthermore, we identified rare noncoding variants in both cohorts that were predicted to affect transcription factor binding sites or cause cryptic splicing. Last, we selected a subset of discovered genes for validation by CRISPR knockdown screening and found that DMBT1, HP1BP3 , and ZCH7B3 have profound impacts on proliferation. This study performs comprehensive surveillance of the genomic landscape of familial glioma.